These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8675154)

  • 1. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
    Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F
    Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and endothelial markers are increased in patients with chronic liver diseases.
    Remková A; Remko M
    Eur J Intern Med; 2009 Sep; 20(5):482-6. PubMed ID: 19712849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.
    van Genderen PJ; Boertjes RC; van Mourik JA
    Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men.
    Jilma B; Cvitko T; Winter-Fabry A; Petroczi K; Quehenberger P; Blann AD
    Thromb Haemost; 2005 Oct; 94(4):797-801. PubMed ID: 16270633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor as a marker of endothelial cell activation following BMT.
    Collins PW; Gutteridge CN; O'Driscoll A; Blair S; Jones L; Aitchison R; Kelsey SM; Chopra R; Goldstone A; Newland AC
    Bone Marrow Transplant; 1992 Dec; 10(6):499-506. PubMed ID: 1490199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
    Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
    J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelin, endothelial cells and von Willebrand factor in peripheral blood of asthmatic patients].
    Krasnowska M; Nittner-Marszalska M; Krasnowski R; Kopeć W
    Pol Merkur Lekarski; 2002 Jun; 12(72):445-8. PubMed ID: 12362657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma.
    Brown SA; Collins PW; Bowen DJ
    Thromb Haemost; 2002 Jun; 87(6):990-6. PubMed ID: 12083507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy.
    Aukrust P; Bjørnsen S; Lunden B; Otterdal K; Ng EC; Ameln W; Ueland T; Müller F; Solum NO; Brosstad F; Frøland SS
    Thromb Haemost; 2000 Aug; 84(2):183-7. PubMed ID: 10959687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.